Company registration number 07073976 (England and Wales)
P H D ANAESTHESIA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
P H D ANAESTHESIA LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
P H D ANAESTHESIA LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
5
357,458
332,467
Current assets
Debtors
6
17,229
14,350
Cash at bank and in hand
21,825
4,424
39,054
18,774
Creditors: amounts falling due within one year
7
(40,973)
(29,771)
Net current liabilities
(1,919)
(10,997)
Net assets
355,539
321,470
Capital and reserves
Called up share capital
103
103
Revaluation reserve
8
2,450
2,450
Profit and loss reserves
352,986
318,917
Total equity
355,539
321,470

The notes on pages 2 to 6 form part of these financial statements.

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 11 June 2026 and are signed on its behalf by:
Dr P H Dodd
Director
Company registration number 07073976 (England and Wales)
P H D ANAESTHESIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

P H D Anaesthesia Limited is a private company limited by shares incorporated in England and Wales. The registered office is c/o SAL 94 West Parade, Lincoln, LN1 1JZ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of services provided to customers net of value added tax and other sales taxes.

- medical consultancy

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

P H D ANAESTHESIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 3 -

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

P H D ANAESTHESIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
P H D ANAESTHESIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 5 -
4
Intangible fixed assets
Goodwill
£
Cost
At 1 December 2024 and 30 November 2025
44,000
Amortisation and impairment
At 1 December 2024 and 30 November 2025
44,000
Carrying amount
At 30 November 2025
-
0
At 30 November 2024
-
0
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
357,458
332,467
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 December 2024
332,467
Additions
24,991
At 30 November 2025
357,458
Carrying amount
At 30 November 2025
357,458
At 30 November 2024
332,467
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
17,229
14,350
P H D ANAESTHESIA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
21,467
11,826
Other taxation and social security
939
438
Other creditors
18,567
17,507
40,973
29,771
8
Revaluation reserve
2025
2024
£
£
At the beginning of the year
2,450
(14,033)
Other movements
-
16,483
At the end of the year
2,450
2,450
2025-11-30 2024-12-01 false false false 11 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr P H Dodd Mrs S M Dodd 07073976 2024-12-01 2025-11-30 07073976 2025-11-30 07073976 2024-11-30 07073976 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 07073976 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 07073976 core:CurrentFinancialInstruments 2025-11-30 07073976 core:CurrentFinancialInstruments 2024-11-30 07073976 core:ShareCapital 2025-11-30 07073976 core:ShareCapital 2024-11-30 07073976 core:RevaluationReserve 2025-11-30 07073976 core:RevaluationReserve 2024-11-30 07073976 core:RetainedEarningsAccumulatedLosses 2025-11-30 07073976 core:RetainedEarningsAccumulatedLosses 2024-11-30 07073976 core:RevaluationReserve 2024-11-30 07073976 core:RevaluationReserve 2023-11-30 07073976 bus:Director1 2024-12-01 2025-11-30 07073976 core:Goodwill 2024-12-01 2025-11-30 07073976 2023-12-01 2024-11-30 07073976 core:NetGoodwill 2024-11-30 07073976 core:NetGoodwill 2025-11-30 07073976 core:NetGoodwill 2024-11-30 07073976 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 07073976 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 07073976 bus:FRS102 2024-12-01 2025-11-30 07073976 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 07073976 bus:Director2 2024-12-01 2025-11-30 07073976 bus:FullAccounts 2024-12-01 2025-11-30 xbrli:pure xbrli:shares iso4217:GBP